What is the recommended dose of Tranexamic Acid (TXA) in an emergency setting?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended TXA Dose in Emergency Settings

Administer tranexamic acid 1 g intravenously over 10 minutes as a loading dose, followed by 1 g infusion over 8 hours, starting as early as possible and within 3 hours of injury. 1, 2

Standard Dosing Protocol

The evidence strongly supports a two-phase dosing regimen for trauma patients with active bleeding or hemorrhagic shock:

  • Loading dose: 1 g IV over 10 minutes 1, 2
  • Maintenance infusion: 1 g IV over 8 hours 1, 2
  • Infusion rate caution: Administer no faster than 1 mL/minute to avoid hypotension 3

Critical Timing Considerations

Time is absolutely critical for TXA effectiveness:

  • Optimal window: Administer within 3 hours of injury 1, 2
  • Effectiveness decay: TXA loses approximately 10% effectiveness for every 15-minute delay 2, 4
  • After 3 hours: Administration beyond 3 hours may actually increase risk of death from bleeding and should be avoided 2, 4, 5
  • Pre-hospital administration: Consider giving the first dose en route to hospital to ensure early treatment 1, 2

Alternative Dosing Strategy

Recent evidence suggests a simplified approach may be equally effective:

  • Single 2 g bolus: A 2024 comparative study found that a single 2 g IV bolus produced equivalent 28-day mortality (21%) compared to the traditional 1 g + 1 g infusion regimen 6
  • Practical advantage: Single bolus administration eliminates the need for prolonged infusion management 6
  • Current joint position: The 2025 NAEMSP/ACEP/ACS-COT statement acknowledges either a 1 g dose (with hospital-based 1 g infusion) or a 2 g dose as acceptable options 5

Patient Selection Criteria

Administer TXA to trauma patients with:

  • Active bleeding or at risk of significant hemorrhage 1
  • Clinical signs of hemorrhagic shock (hypotension, tachycardia, altered mental status) 5
  • Base deficit >6 mEq/L indicating hypoperfusion 1

Do NOT administer TXA in:

  • Patients beyond 3 hours post-injury 2, 5
  • Active intravascular clotting 3
  • Subarachnoid hemorrhage (contraindicated due to risk of cerebral edema and infarction) 3
  • Known hypersensitivity to tranexamic acid 3

Dose Adjustments for Renal Impairment

Reduce dosing in patients with renal dysfunction: 3

  • Serum creatinine 1.36-2.83 mg/dL: 10 mg/kg twice daily
  • Serum creatinine 2.83-5.66 mg/dL: 10 mg/kg once daily
  • Serum creatinine >5.66 mg/dL: 10 mg/kg every 48 hours or 5 mg/kg every 24 hours

Pediatric Considerations

  • No established prehospital dosing: The role of TXA in pediatric trauma has not been adequately studied 5
  • If used: Administer within 3 hours of injury, though specific weight-based dosing remains undefined 5
  • Alternative reference: Some guidelines suggest 15 mg/kg loading dose followed by 2 mg/kg/hour infusion for pediatric trauma, though this is extrapolated from adult data 2

Safety Monitoring

Key adverse events to monitor:

  • Seizures: Most commonly reported with doses >100 mg/kg, particularly in cardiac surgery (not trauma) settings 2, 3
  • Thromboembolism: Risk appears low in trauma patients; CRASH-2 trial showed lower thrombosis rates with TXA compared to placebo 1
  • Hypotension: Can occur with rapid infusion; maintain infusion rate ≤1 mL/minute 3
  • Hypersensitivity reactions: Including anaphylaxis; discontinue immediately if occurs 3

Route of Administration

  • Intravenous is the only recommended route for emergency trauma use 2, 4
  • Intraosseous access is acceptable if IV access cannot be obtained 5
  • Never administer intrathecally: Serious adverse reactions including seizures and cardiac arrhythmias have occurred with inadvertent neuraxial administration 3

Common Pitfalls to Avoid

  • Delaying administration: Every 15-minute delay reduces effectiveness by 10%; prioritize early administration 2
  • Giving after 3 hours: This may harm rather than help the patient 2, 5
  • Using in isolated traumatic brain injury without hemorrhagic shock: Evidence supports TXA in TBI only when administered within 3 hours for mild-moderate injury, but standard trauma dosing applies 2
  • Confusing with other injectable solutions: Clearly label syringes with "IV ONLY" to prevent wrong-route errors 3
  • Mixing with incompatible solutions: Do not mix with blood products or penicillin-containing solutions 3

Communication and Quality Assurance

  • Document and communicate: Clearly inform receiving hospital staff of TXA administration to prevent duplicate dosing 5
  • Quality monitoring: Establish multidisciplinary oversight including EMS physicians, emergency physicians, and trauma surgeons to track protocol compliance and complications 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Tranexamic Acid Dosage and Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Tranexamic Acid Administration for Stroke

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.